Studies also indicate that METTL16 is associated with poor prognosis in colorectal cancer (CRC), as it binds with IGF2BP1 to significantly increase SOGA1 expression and mRNA stability, contributing to METTL16-mediated glycolysis and CRC growth (Wei et al., 2023). Here, MTCL2 is linked to colorectal carcinoma.